Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EXL01 |
| Trade Name | |
| Synonyms | F. prausnitzii strain EXL01 |
| Drug Descriptions |
EXL01 is a strain of Faecalibacterium prausnitzii, which may enhance antitumor immune response (PMID: 38957477). |
| DrugClasses | Microbiome 9 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + Bevacizumab + EXL01 | Atezolizumab Bevacizumab EXL01 | 0 | 1 |
| EXL01 | EXL01 | 0 | 0 |
| EXL01 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin | EXL01 Fluorouracil Leucovorin Nivolumab Oxaliplatin | 0 | 1 |
| EXL01 + Ipilimumab + Nivolumab | EXL01 Ipilimumab Nivolumab | 0 | 1 |
| EXL01 + Nivolumab | EXL01 Nivolumab | 0 | 1 |
| EXL01 + unspecified PD-L1 antibody | EXL01 unspecified PD-L1 antibody | 0 | 0 |